These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1608 related items for PubMed ID: 22329591

  • 1. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L.
    Am J Cardiovasc Drugs; 2012 Apr 01; 12(2):137-42. PubMed ID: 22329591
    [Abstract] [Full Text] [Related]

  • 2. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov 01; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC, Oh YS, Cha DH, Hong SJ, Won KH, Yoo KD, Rha SW, Ahn YK, Ahn JC, Jang JY, Hong TJ, Cho SK, Park SH, Hyon MS, Nam CW, Chae IH, Yoo BS, Song JM, Jeong JO, Yoon YW, Kim BS, Yang TH, Cho DK, Kim SH, Choi YJ, Ahn JH, Jeon DW, Kim HS.
    Clin Ther; 2018 Jan 01; 40(1):50-63.e3. PubMed ID: 29248384
    [Abstract] [Full Text] [Related]

  • 4. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
    Ando K, Isshiki M, Takahashi K, ONgoing Evaluation of depressor effect And Safety of combination therapy with Telmisartan and low-dose hydrochlorothiazide (ONEAST) Study Group.
    Hypertens Res; 2009 Sep 01; 32(9):748-52. PubMed ID: 19590506
    [Abstract] [Full Text] [Related]

  • 5. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
    Segura J, Ruilope LM.
    Vasc Health Risk Manag; 2013 Sep 01; 9():521-8. PubMed ID: 24082785
    [Abstract] [Full Text] [Related]

  • 6. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 01; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 01; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 8. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
    Neldam S, Edwards C.
    Expert Opin Pharmacother; 2009 Feb 01; 10(3):345-52. PubMed ID: 19191674
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
    Zhu DL, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM.
    Clin Ther; 2012 Jul 01; 34(7):1613-24. PubMed ID: 22717420
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
    Fogari R, Mugellini A, Derosa G, CANDIA (CANdesartan and DIuretic vs. Amlodipine in hypertensive patients) Study Group.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep 01; 8(3):139-44. PubMed ID: 17907102
    [Abstract] [Full Text] [Related]

  • 11. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
    Jayaram S, Lahoti S, Chandrasekharan S, Ganesan R, Muralidharan RS, Mishra AB, Sodhi SS, Rajadhyaksha GC, Jain SD, Kadam GS, Gawde A, Desai A.
    J Indian Med Assoc; 2004 Sep 01; 102(9):525-7. PubMed ID: 15887845
    [Abstract] [Full Text] [Related]

  • 12. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
    Guthrie RM.
    Postgrad Med; 2011 Nov 01; 123(6):58-65. PubMed ID: 22104454
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients.
    Guthrie RM, Dahlöf B, Jamerson KA, Olvera R, Seeber M, Schumacher H, Oigman W.
    Curr Med Res Opin; 2011 Oct 01; 27(10):1995-2008. PubMed ID: 21905967
    [Abstract] [Full Text] [Related]

  • 14. An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors.
    Kjeldsen S, Mancia G, Schmieder R, Mattheus M, Unger T.
    Expert Rev Cardiovasc Ther; 2013 Jun 01; 11(6):673-82. PubMed ID: 23750676
    [Abstract] [Full Text] [Related]

  • 15. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
    Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE.
    Vasc Health Risk Manag; 2015 Jun 01; 11():1-8. PubMed ID: 25565857
    [Abstract] [Full Text] [Related]

  • 16. Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
    Sharma AM, Bakris G, Neutel JM, Littlejohn TW, Kobe M, Ting N, Ley L.
    Clin Ther; 2012 Mar 01; 34(3):537-51. PubMed ID: 22386829
    [Abstract] [Full Text] [Related]

  • 17. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA, ACCOMPLISH Trial investigators.
    Lancet; 2010 Apr 03; 375(9721):1173-81. PubMed ID: 20170948
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
    Higaki J, Komuro I, Shiki K, Ugai H, Taniguchi A, Ikeda H, Kuroki D, Nishimura S, Ogihara T.
    Hypertens Res; 2017 Jan 03; 40(1):51-60. PubMed ID: 27581533
    [Abstract] [Full Text] [Related]

  • 19. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
    Littlejohn TW, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R, Oigman W, study investigators.
    Postgrad Med; 2009 Mar 03; 121(2):5-14. PubMed ID: 19332958
    [Abstract] [Full Text] [Related]

  • 20. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S, Chrysant SG, Melino M, Lee J, Karki S, Heyrman R.
    J Hum Hypertens; 2010 Dec 03; 24(12):831-8. PubMed ID: 20200547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.